
AI Innovations in Immunotherapy: The Role of Immunogenomics, Radiomics, and Pathomics
AI enhances immunotherapy through genomics, radiomics, and pathomics, improving personalized treatment strategies. π§¬π»π
Discover the newest research about AI innovations in π Oncology.
AI enhances immunotherapy through genomics, radiomics, and pathomics, improving personalized treatment strategies. π§¬π»π
Viz.ai and Novartis are collaborating to enhance cancer care using AI. New tools will improve patient identification and treatment coordination. π©Ίπ»
“Liquid biopsy revolutionizes cancer detection! π Blood ctDNA analysis leads research, enhancing precision medicine in 2024. π©Έ”
Radiomics differentiates UTUC from RCC with 88.4% sensitivity. Machine learning enhances preoperative CT diagnostics. ππ©Ί
AI technology estimates biological age from facial images, aiding cancer prognosis and treatment decisions. πΈπ§¬
Anticancer peptides show promise in targeting tumors with low toxicity. Key findings from PubMed article reviewed. π§¬π
National Taiwan University Hospital introduces AI for pancreatic cancer imaging, enhancing early detection and diagnostic accuracy. π₯π»
Novel Chemotherapy Benefit Index for Advanced Ovarian Cancer: Key Genes, Survival Rates, and Immunotherapy Insights ππ
New machine prototype detects breast cancer in dense tissue. Clinical trials to follow after testing phase. π©Ίπ‘
AI-driven tool enhances breast cancer treatment for older adults, achieving 0.81 AUC in mortality prediction. ππ‘